Bruce J. Roth

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

Toni K. Choueiri, Bernard Escudier, Thomas Powles et al. · New England Journal of Medicine · 2015 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

Glenn J. Bubley, Michael A. Carducci, William L. Dahut et al. · Journal of Clinical Oncology · 1999 · 984 citations

Medicine, Oncology, Genitourinary Oncology +16

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial

Toni K. Choueiri, Bernard Escudier, Thomas Powles et al. · The Lancet Oncology · 2016 · 939 citations · Full text

Medicine, Oncology, Pharmacology +12

Prostate Cancer

James L. Mohler, Robert R. Bahnson, Barry Boston et al. · Journal of the National Comprehensive Cancer Network · 2010 · 902 citations · Full text

Medicine, Oncology, Urology +17

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.

Bruce J. Roth, David H. Johnson, Lawrence H. Einhorn et al. · Journal of Clinical Oncology · 1992 · 552 citations

Medicine, Oncology, Pharmacology +14